Register Login

Krystal Biotech (KRYS)

(90% Positive) KRYSTAL BIOTECH, INC. (KRYS) Announces Enrollment Update for timelines Due to Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment

Full text
Register to leave comments
  • News bot Jan. 8, 2026, 9:38 p.m.

    📋 KRYSTAL BIOTECH, INC. (KRYS) - Clinical Trial Update

    Filing Date: 2026-01-08

    Accepted: 2026-01-08 16:35:06

    Event Type: Clinical Trial Update

    Event Details:

    Krystal Biotech (KRYS) Announces Clinical Trial Update Krystal Biotech (KRYS) provided an update on its clinical development programs. Clinical Development Highlights:
    • Drug Program: timelines, transduced
    • Diseases/Conditions: late December
    • Clinical Stage: Phase 1 study, Phase 1
    • Collaboration: CORAL-3

    💼 Business Developments:

    • Partnership: Not available
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: Krystal Biotech
    • CIK: 0001711279
    • Ticker Symbol: KRYS
    • Period End Date: 2026-01-08
    • Document Type: 8-K

Search

News categories